Phytoestrogens decrease brain calcium-binding proteins but do not alter hypothalamic androgen metabolizing enzymes in adult male rats

Brain Research

Volumn 859, Issue 1, 2000, Pages 123-131

  Lephart, Edwin D ^a   Thompson, Joseph M ^a   Setchell, Kenneth D R ^b   Adlercreutz, Herman ^c   Weber, K Scott ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

5 Reductase; Aromatase; Calbindin; Calretinin; Hypothalamus; Phytoestrogens; Rat; Soy; Western

Indexed keywords

CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; DAIDZEIN; GENISTEIN; STEROID 5ALPHA REDUCTASE;

ANDROGEN METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANDROGENS; ANIMALS; AROMATASE; BLOTTING, WESTERN; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CALCIUM-BINDING PROTEINS; CHOLESTENONE 5 ALPHA-REDUCTASE; ESTROGENS, NON-STEROIDAL; HYPOTHALAMUS; ISOFLAVONES; MALE; OXIDOREDUCTASES; PHYTOESTROGENS; PLANT PREPARATIONS; PREOPTIC AREA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034678030     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)01968-5     Document Type: Article

References (52)

1. H. Adlercreutz, Evolution, nutrition, intestinal microflora, and prevention of cancer: a hypothesis, Proc. Soc. Exp. Biol. Med. 217 (1997) 241-246.
2. H. Adlercreutz, C. Bannwart, K. Wahala, T. Makela, G. Brunow, T. Hase, P.J. Arosemena, J.T. Kellis Jr., L.E. Vickery, Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens, J. Steroid Biochem. Mol. Biol. 44 (1994) 147-153.
3. H. Adlercreutz, W. Mazur, Phyto-estrogens and Western diets, Ann. Med. 29 (1997) 95-120.
4. K.G. Baimbridge, M.R. Celio, J.H. Roger, Calcium-binding proteins in the nervous system, Trends Neurosci. 15 (1992) 303-308.
5. F. Celotti, C. Melcangi, L. Martini, The 5α-reductase in the brain: molecular aspects and relation to brain function, Front. Neuroendocrinol. 13 (1992) 163-215.
6. L. Coward, N.C. Barnes, K.D.R. Setchell, S. Barnes, Genistein, daidzein, and their β-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets, J. Agric. Food Chem. 41 (1993) 1961-1967.
7. B.A. Evans, K. Griffiths, M.S. Morton, Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids, J. Endocrinol. 147 (1995) 295-302.
8. K.A. Faber, C.L. Hughes Jr., The effect of neonatal exposure to diethylstilbestrol, genistein, and zearalenone on pituitary responsiveness and sexually dimorphic nucleus volume in the castrated adult rat, Biol. Reprod. 45 (1991) 649-653.
9. K.A. Faber, C.L. Hughes Jr., Dose-response characteristics of neonatal exposure to genistein on pituitary responsiveness to gonadotropin releasing hormone and volume of the sexually dimorphic nucleus of the preoptic area (SDN-POA) in postpubertal castrated female rats, Reprod. Toxicol. 7 (1993) 35-39.
10. P.H. Gamache, T.J. Maher, K.D.R. Setchell, T.-H. Wu, I.N. Acworth, The transfer of non-steroidal dietary estrogens into brain, Soc. Neurosci. Abstr. 22 (1996) 1967.
11. R.K. Gill, S. Christakos, Regulation by estrogen through the 5′-flanking region of the mouse calbindin-28K gene, Mol. Endocrinol. 9 (1995) 319-326.
12. V.W. Henderson, Estrogen, cognition, and a woman's risk of Alzheimer's disease, Am. J. Med. 103 (1997) 11S-18S.
13. 28K a potential neuroprotective protein, Neurodegeneration 3 (1994) 1-20.
14. A.R. Ibrahim, Y.J. Abul-Hajj, Aromatase inhibition by flavonoids, J. Steroid Biochem. Mol. Biol. 37 (1990) 257-260.
15. N.A. Jacobson, D.R. Ladle, E.D. Lephart, Aromatase cytochrome P450 and 5α-reductase in the amygdala and cortex of perinatal rats, NeuroReport 8 (1997) 2529-2533.
16. J.T. Kellis Jr., L.E. Vickery, Inhibition of human estrogen synthetase (aromatase) by flavones, Science 225 (1984) 1032-1034.
17. D.C. Knight, J.A. Eden, A review of the clinical effects of phytoestrogens, Obstet. Gynecol. 87 (1996) 897-904.
18. G.G.J.M. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Haggbald, S. Nilsson, J. Gustafsson, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β, Endocrinology 138 (1997) 863-870.
19. G.G. Kuiper, P.J. Shughrue, I. Merchenthaler, J.A. Gustafsson, The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems, Front. Neuroendocrinol. 19 (1998) 253-286.
20. E.D. Lephart, A review of brain 5α-reductase: cellular, enzymatic, and molecular perspectives and implications for biological function, Mol. Cell. Neurosci. 4 (1993) 473-484.
21. E.D. Lephart, A review of brain aromatase cytochrome P450, Brain Res. Rev. 22 (1996) 1-26.
22. 28K in the medial basal hypothalamus from perinatal male and female rats, Dev. Brain Res. 96 (1996) 281-284.
23. E.D. Lephart, S. Andersson, E.R. Simpson, Expression of neural 5α-reductase messenger ribonucleic acid: comparison to 5α-reductase activity during prenatal development in the rat, Endocrinol. 127 (1990) 1121-1128.
24. E.D. Lephart, E.R. Simpson, Techniques for the assay of aromatase activity, in: M.R. Waterman, E.F. Johnson (Eds.), Methods of Enzymology, Vol. 206, Academic Press, Orlando, 1991, pp. 477-483.
25. E.D. Lephart, E.R. Simpson, M.J. McPhaul, M.W. Kilgore, J.D. Wilson, S.R. Ojeda, Brain aromatase cytochrome P-450 messenger RNA levels and enzyme activity during prenatal and perinatal development in the rat, Mol. Brain Res. 16 (1992) 187-192.
26. 28K in male rats during postnatal development, Neurobiol. Aging 19 (1998) 253-257.
27. 28K in male and female infantile rats, Neurosci. Lett. 267 (1999) 41-44.
28. E.D. Lephart, M.A. Watson, L. Mathias, R.W. Rhees, S. Diano, T.L. Horvath, Co-localization of aromatase cytochrome P450 and calbindin-D28K and androgen regulation of calbindin-28K during perinatal development, Soc. Neurosci. Abstr. 23 (1997) 342.
29. E.D. Lephart, M.A. Watson, R.W. Rhees, D.R. Ladle, N.A. Jacobson, Development expression of calretinin in the medial basal hypothalamus and amygdala from male and female fats, Neurosci. Res. 28 (1997) 269-273.
30. O.H. Lowry, N.J. Rosenbrough, A.L. Farr, R.J. Randall, Protein determination with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
31. M.P. Mattson, Calcium as sculptor and destroyer of neural circuitry, Exp. Gerontol. 27 (1992) 29-49.
32. B.S. McEwen, Clinical review 108: the molecular and neuroanatomical basis for estrogen effects in the central nervous system, J. Clin. Endocrinol. Metab. 84 (1999) 1790-1797.
33. A.L. Murkies, G. Wilcox, S.R. Davis, Phytoestrogens - review, J. Clin. Endocrinol. Metab. 83 (1998) 297-303.
34. P.A. Murphy, Phytoestrogen content of processed soybean products, Food Technol. 34 (1982) 60-64.
35. F. Naftolin, Brain aromatization of androgens, J. Reprod. Med. 39 (1994) 257-261.
36. H.B. Patisaul, P.L. Whitten, L.J. Young, Regulation of estrogen receptor beta MRNA in the brain: opposite effects of 17beta-estradiol and the phytoestrogen, coumestrol, Mol. Brain Res. 67 (1999) 165-171.
37. D.N. Petersen, G.T. Tkalcevic, P.H. Koza-Taylor, T.G. Turi, T.A. Brown, Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues, Endocrinology 139 (1998) 1082-1092.
38. A. Poletti, P. Negri-Cesi, M. Rabuffetti, A. Colciago, F. Celotti, L. Martini, Transient expression of the 5α-reductase type 2 isozyme in the rat brain in late fetal and early postnatal life, Endocrinology 139 (1998) 2171-2178.
39. K.R. Price, G.R. Fenwick, Naturally occurring oestrogens in foods - a review, Food Addit. Contam. 2 (1995) 73-106.
40. S. Seely, Diet and cerebrovascular disease: search for linkages, Med. Hypotheses 9 (1982) 509-515.
41. K.D.R. Setchell, Naturally occurring non-steroidal estrogens of dietary origin, in: J. McLachlan (Ed.), Estrogens in the Environment: Influence on Development, Elsevier, New York, 1985, pp. 69-85.
42. K.D.R. Setchell, Phytoestrogens: biochemistry, physiology and implications for human health of soy isoflavones, Am. J. Clin. Nutr. 68 (1998) 1333S-1346S.
43. K.D.R. Setchell, A. Cassidy, Dietary isoflavones - biological effects and relevance to human health, J. Nutr. 129 (1999) 758S-767S.
44. K.D.R. Setchell, M.B. Welsh, C.K. Lim, High-performance liquid chromatographic analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical and thermospray mass spectrometric detection, J. Chromatogr. 386 (1987) 315-323.
45. K.D.R. Setchell, L. Zimmer-Nechemias, J. Cai, J.E. Heubi, Exposure of infants to phyto-oestrogens from soy-based infant formula, Lancet 350 (1997) 23-27.
46. B.B. Sherwin, Estrogen and cognitive function in women, Proc. Soc. Exp. Biol. Med. 217 (1998) 17-22.
47. J.W. Simpkins, P.S. Green, K.E. Gridley, M. Singh, N.C. de Fiebre, G. Rajakumar, Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease, Am. J. Med. 103 (1997) 19S-25S.
48. E. Stuart, E.D. Lephart, Dimorphic expression of MBH-POA calbindin mRNA levels during perinatal development and adult brain tissue distribution of calbindin mRNA, Mol. Brain. Res. 73 (1999) 60-67.
49. 28K levels during prenatal development, Dev. Brain Res. 114 (1999) 277-281.
50. C. Wang, T. Makela, T. Hase, H. Adlercreutz, M.S. Kurzer, Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes, J. Steroid Biochem. Mol. Biol. 50 (1994) 205-212.
51. 28K in hypothalamic tissue during prenatal development, Neurosci. Res. 32 (1998) 97-101.
52. K.S. Weber, N.A. Jacobson, K.D.R. Setchell, E.D. Lephart, Brain aromatase and 5α-reductase, regulatory behaviors and testosterone levels in adult rats on phytoestrogen diets, Proc. Soc. Exp. Biol. Med. 22 (1999) 131-135.